|
24647
|
Ratio SARS-CoV-2 S/N IgG
Panel
Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome
|
|
Serum (2×) |
|
72 (3) |
–
|
—
|
—
|
› |
|
28129
|
Respiratoire pathogenen
Panel
Respiratoire micro-organismen panel, Viraal panel
|
|
DNA-wisser |
|
68 (2,8) |
–
|
—
|
—
|
› |
|
21202
|
Reticulocyten index
Panel
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
351
|
RhD-moleculair
Panel
|
|
EDTA |
|
166 (6,9) |
–
|
—
|
—
|
› |
|
57496
|
Rhodium /g creatinine
Panel
Rh
|
|
Urine |
|
250 (10,4) |
–
|
—
|
—
|
› |
|
6122
|
Risperidone
Panel
9-hydroxyrisperidon, 9-hydroxyrisperidone, Invega
|
|
Serum |
|
128 (5,3) |
–
|
—
|
—
|
› |
|
69862
|
Rkn.pt.fRhD genotypering
Panel
|
|
EDTA |
|
172 (7,2) |
–
|
—
|
—
|
› |
|
24574
|
Rubella bevestiging
Panel
|
|
Serum |
|
20 (0,8) |
–
|
—
|
—
|
› |
|
57476
|
Ruthenium /g creatinine
Panel
|
|
Urine |
|
282 (11,7) |
–
|
—
|
—
|
› |
